As demonstrated by the chart below, we can see the darkpool market has been selling (purple line) the $SPY. (blue line price) DarkPool trading represents large institutions, like $JPM, $GS, $MS and others. DarkPools are allowed their “own market,” which…
Author: Scott Matusow
Video/Audio: A Message From Scott Matusow
In this video, I want to explain a little more what we do at stockmatusow and how we are working to make it better for you, not only to help you make money in the market, but how to protect…
Video Market Commentary For May 4th, 2014 – Ukraine and China Issues
Video Market Commentayy For May 4th, 2014 – Ukraine and China Issues will dominate market this week which should take the markets downwards towards the bottom of their respective ranges. I forgot to comment on $SYN data on this video,…
Video And Text Market Commentary And Charts For Thursday May 1, 2014
Video Market Commentary And Charts For Thursday May 1, 2014. In this video, I review $CYTK, $SGYP, $XOMA, and $ARAY. Additionally, I delve more into the current market macros and look and preview tomorrow’s trading action. Today we saw some…
Cytokinetics Binary Failure Provides Solid Buying Opportunity For Traders And Speculation Investors
Seeking Alpha preview: Written by Michael Kovar and Scott Matusow in stock price for Cytokinetics (CYTK) prior to the recent data released last Friday. Indeed, that did occur as the stock went from $10.63 to a high of $13.26, representing…
Video Market Commentary For April 29 2014 – $SYN situation explained + $CYTK
Video Market Commentary For April 29 2014 – $SYN situation explained + $CYTK. Reasons for $SYN sell off late – not manipulation by “market makers” More in line with apparent company spin + 24 month data relapses should be less,…
Video Chart Review and Commentary For Monday, April 28 2014
Chart Review and Commentary For Monday, April 28 2014 $POZN $SYN, $CPE, $KOOL, $SGYP reviewed and discussed. Confusing Macro indicators , at least for me at this very moment — makes it hard to predict market move for tomorrow. $IBB…
Did Pozen Mislead Investors Concerning Its Recent FDA Rejection?
On Friday of last week, Pozen Inc.(POZN), received a CRL from the FDA, disallowing the New Drug Application (NDA) for its coordinated-delivery tablet combination of omeprazole (Prilosec) and aspirin. This combination can basically be purchased over the counter (OTC) by…
Video Chart Review and Commentary For Sunday, April 27 2014
Chart Review and Commentary For Sunday, April 27 2014. $SYN and $POZN reviewed and situations explained. Additional market commentary. This is a short video as I plan to make another one later, time permitting, enjoy! Scott
Video Market Commentary For April 25, 2014
Video Market Commentary For April 25, 2014. $SYN potential result scenario discussed, $POZN potential trade thesis discussed, $IBB levels discussed + Ukraine situation and general macros, enjoy! Scott